Eddie Hickman's Stock Ratings

Guggenheim Analyst

Eddie Hickman is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

12.8%

Smart Score

61%

Overall Average Return Percentile

70th

Number of Ratings

16
Buy NowGet Alert
03/13/2025ZVRABuy Now
Zevra Therapeutics
$7.97176.04%
Eddie Hickman60%
$20 → $22MaintainsBuyGet Alert
03/13/2025GHRSBuy Now
GH Research
$10.60201.89%
Eddie Hickman60%
→ $32Initiates → BuyGet Alert
03/13/2025CYBNBuy Now
Cybin
$7.49367.29%
Eddie Hickman60%
→ $35Initiates → BuyGet Alert
02/26/2025PMNBuy Now
ProMIS Neurosciences
$0.73
Eddie Hickman60%
ReiteratesBuy → BuyGet Alert
02/26/2025TARSBuy Now
Tarsus Pharmaceuticals
$46.1768.94%
Eddie Hickman60%
$75 → $78MaintainsBuyGet Alert
02/24/2025TARSBuy Now
Tarsus Pharmaceuticals
$46.17
Eddie Hickman60%
ReiteratesBuy → BuyGet Alert
02/10/2025TARSBuy Now
Tarsus Pharmaceuticals
$46.17
Eddie Hickman60%
ReiteratesBuy → BuyGet Alert
01/17/2025OTLKBuy Now
Outlook Therapeutics
$1.54679.22%
Eddie Hickman60%
$12 → $12ReiteratesBuy → BuyGet Alert
01/25/2024OTLKBuy Now
Outlook Therapeutics
$1.5429.87%
Eddie Hickman60%
→ $40UpgradeNeutral → BuyGet Alert
09/11/2023TARSBuy Now
Tarsus Pharmaceuticals
$46.176.13%
Eddie Hickman60%
$46 → $49MaintainsBuyGet Alert
08/14/2023TARSBuy Now
Tarsus Pharmaceuticals
$46.17-0.37%
Eddie Hickman60%
→ $46ReiteratesBuy → BuyGet Alert
06/16/2023TARSBuy Now
Tarsus Pharmaceuticals
$46.17-9.03%
Eddie Hickman60%
$40 → $42MaintainsBuyGet Alert
05/18/2023TARSBuy Now
Tarsus Pharmaceuticals
$46.17
Eddie Hickman60%
Initiates → BuyGet Alert
05/01/2023ISEEBuy Now
IVERIC bio
Eddie Hickman60%
DowngradeBuy → NeutralGet Alert
04/03/2023OTLKBuy Now
Outlook Therapeutics
$1.54224.68%
Eddie Hickman60%
→ $100Initiates → BuyGet Alert
09/07/2022ISEEBuy Now
IVERIC bio
Eddie Hickman60%
$30 → $35MaintainsBuyGet Alert
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free